triple agonist glp-1 retatrutide gip glucagon receptor Sweet Temptation, bitter Truth: Diabetes in the Research Spotlight GLP-1 Medications for Weight Loss:
Description
With a single molecule approach, the ratio of activities of the constituents, however, will be fixed, whereas individual combination therapies present the potential benefit of being titratable to allow more optimal ratio between doses of the agonists
Metabolism The metabolism of common GLP-1 RAs varies across agents: Exenatide undergoes hydrolysis in the kidneys and liver, producing smaller inactive peptides excreted via the kidneys (23)
The benefits and risks of this medication should be carefully weighed on an individual basis
List of adverse reactions of SSIBs included in this study
W., et al
